GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kim Forest Enterprise Co Ltd (TPE:6645) » Definitions » Valuation Rank

Kim Forest Enterprise Co (TPE:6645) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Kim Forest Enterprise Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Kim Forest Enterprise Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Kim Forest Enterprise Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Kim Forest Enterprise Co Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Xintai 5th Road, 30th Floor, Section 1, U-TOWN Building B, Xizhi District, New Taipei, TWN, 22175
Kim Forest Enterprise Co Ltd is engaged in providing clinical medical information, genetic testing services, and biological information. It manufactures medical equipment and also produces drug products. The company's equipment includes Desktop microcentrifuge, Desktop large capacity centrifuge, Filter-type absorption spectrometer, Multifunctional spectrometer, and many more. Its reportable segments are Biomedical products which generates key revenue, and the Precision medicine segment. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States of America.